ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 588,30
-0,58%
Dow Jones
40 211,72
0,53%
DAX
18 519,99
-0,43%
Brent Oil
83,655
-0,81%
Bitcoin
63 205,58
-2,54%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
16/02/201817h39Business WireTeva Announces U.S. Launch of QVAR® RediHaler™ (Beclomethasone Dipropionate HFA) Inhalation AerosolNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201815h00Business WireTeva Announces Launch of a Generic Version of Syprine® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201809h02Dow Jones NewsTeva Sustains $11.6 Billion Loss -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
08/02/201820h24Dow Jones NewsTeva Pharmaceutical Shares Plunge After Quarterly Loss and 2018 Outlook WarningNYSE:TEVATeva Pharmaceutical Industries Ltd
08/02/201813h00Business WireTeva Reports 2017 Full Year and Fourth Quarter Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/02/201813h00Business WireEuropean Medicines Agency (EMA) Accepts Fremanezumab Marketing Authorization ApplicationNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201814h26Business WireTeva Completes Amendment to Credit FacilitiesNYSE:TEVATeva Pharmaceutical Industries Ltd
01/02/201813h00Business WireTeva Announces Completion of Global Women’s Health Divestiture to CVC Capital PartnersNYSE:TEVATeva Pharmaceutical Industries Ltd
25/01/201819h00Business WireTeva to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results at 8 a.m. ET on February 8, 2018NYSE:TEVATeva Pharmaceutical Industries Ltd
22/01/201814h00Business WireTeva Announces Top-Line Results from Phase III Studies of Subcutaneously Administered Reslizumab in Patients with Severe Eosi...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/01/201814h00Business WireTeva Announces U.S. FDA Approval of TRISENOX® (arsenic trioxide) Injection for First Line Treatment of Acute Promyelocytic L...NYSE:TEVATeva Pharmaceutical Industries Ltd
12/01/201809h02Dow Jones NewsOhio Talks Settlement Of Opioid Lawsuits -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
12/01/201800h00Dow Jones NewsADRs End Slightly Higher; Teva, Ryanair, SAP Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
11/01/201823h20Dow Jones NewsOhio Takes Steps Toward Resolution of Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
11/01/201820h52Dow Jones NewsOhio in Talks to Settle Opioid Suit, State Attorney General SaysNYSE:TEVATeva Pharmaceutical Industries Ltd
08/01/201814h00Business WireTeva Announces Global License Agreement with Alder BioPharmaceuticals® in the Field of Anti-CGRP-Based TherapyNYSE:TEVATeva Pharmaceutical Industries Ltd
04/01/201817h12Business WireTeva to Present at the 36th Annual J.P. Morgan Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
02/01/201820h25Business WireTeva Announces Launch of an Authorized Generic of Estrace® Cream in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
27/12/201715h00Business WireTeva Announces Exclusive Launch of a Generic Version of Reyataz® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
18/12/201714h00Business WireFDA Accepts Biologics License Application for Fremanezumab with Priority Review for Prevention of Migraine & Grants Fast Trac...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/12/201715h00Business WireTeva Announces Exclusive Launch of Generic Viread® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/12/201709h02Dow Jones NewsGenerics Giant Cuts Staff by 25% -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
15/12/201700h50Dow Jones NewsADRs End Lower; Teva, Criteo Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201715h25Dow Jones NewsTeva Pharmaceutical to Cut 14,000 Jobs, Suspend Dividend--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201714h15Dow Jones NewsTeva Pharmaceutical to Cut 14,000 JobsNYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201713h03Business WireTeva Announces Restructuring Plan and Additional Measures to Improve Its Business and Financial PerformanceNYSE:TEVATeva Pharmaceutical Industries Ltd
14/12/201700h30Dow Jones NewsADRs End Mostly Higher; China Eastern, Teva Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
13/12/201717h30Business WireTeva to Host Conference Call to Discuss Restructuring Plan & Additional Measures to Improve Its Bus. & Financial Performance ...NYSE:TEVATeva Pharmaceutical Industries Ltd
11/12/201715h13Business WireTeva Announces Exclusive Launch of Generic Viagra® Tablets in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
09/12/201700h20Dow Jones NewsADRs End Higher; Himax Technologies, Teva Pharmaceutical Industries Trade ActivelyNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
AI
Air Liquide
NASDAQ
AAPL
Apple
EU
PX1
CAC 40
EU
VIV
Vivendi
EU
BNP
BNP Paribas
NASDAQ
GOOGL
Alphabet
FTSE
UKX
FTSE 100
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
EU
HO
Thales
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
EN
Bouygues
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés